Spots Global Cancer Trial Database for recurrence
Every month we try and update this database with for recurrence cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| IPC Status as a Surgical Quality Marker in Rectal Cancer Surgery | NCT02081547 | Rectal Cancer | 18 Years - | Uppsala University | ||
| Hepatocarcinoma Recurrence on the Liver Study - Part2 | NCT04053231 | Liver Cancer Surgery Recurrence Tumo... Cirrhosis | liver resection | 18 Years - | University of Milano Bicocca | |
| Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression | NCT02443844 | Bladder Cancer | Transurethral R... Tamsulosin | 40 Years - 80 Years | Diskapi Teaching and Research Hospital | |
| uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto | NCT05874921 | Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Carc... Urothelial Canc... Urothelial Carc... Carcinoma, Tran... Transitional Ce... | Jelmyto (mitomy... | 18 Years - | UroGen Pharma Ltd. | |
| Follow-up Protocol of Colorectal Endoscopic Mucosal Resection Scars | NCT04239365 | Colorectal Canc... Recurrence, Loc... | WLE followed by... | 18 Years - | Portuguese Oncology Institute, Coimbra | |
| Artificial Intelligence and Hepatocellular Carcinoma | NCT05637788 | HCC | CT Scan Radiomi... | 18 Years - | Humanitas Clinical and Research Center | |
| Prospective Sample Collection for Cancer of Bladder | NCT03973671 | Urinary Bladder... | 18 Years - 90 Years | Universitaire Ziekenhuizen KU Leuven | ||
| Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC) | NCT00824746 | Carcinoma, Non-... | Gefitinib retre... | 18 Years - | Chonnam National University Hospital | |
| Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients | NCT00470340 | Liver Neoplasms Liver Cirrhosis Carcinoma, Hepa... Recurrence Neoplasm Recurr... | Oxaliplatin, ge... | 18 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection | NCT02738697 | Carcinoma, Hepa... | Adjuvant chemot... Follow-up | 18 Years - 75 Years | Sun Yat-sen University | |
| PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients | NCT01020604 | Prostate Cancer Obesity | 18 Years - | AstraZeneca | ||
| Pembrolizumab + Idelalisib for Lung Cancer Study | NCT03257722 | Non Small Cell ... Metastasis Recurrence | Pembrolizumab Idelalisib | 18 Years - | Augusta University | |
| Lenvatinib Therapy in HCC Patients After LDLT | NCT05572528 | Liver Transplan... Hepatocellular ... | 18 Years - 75 Years | Kaoshiung Chang Gung Memorial Hospital | ||
| Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer | NCT02484040 | Response to Tox... Toxicity Recurrence | Two-week course... Two-week course... | 20 Years - 80 Years | Seoul St. Mary's Hospital | |
| Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma | NCT02586285 | Hepatocellular ... | S-Adenosyl Meth... | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Sentinel Node Biopsy in Breast Cancer Patients | NCT01351974 | Recurrence Breast Cancer | - | Uppsala University | ||
| Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS | NCT06317896 | Hepatocellular ... Circulating Tum... Recurrence Surgery | circulating tum... | 18 Years - 75 Years | Zhujiang Hospital | |
| Predictive Value of Postoperative Circulating Tumor DNA Monitoring for Colorectal Cancer Recurrence | NCT06143644 | Colorectal Canc... | Serial ctDNA mo... | 18 Years - | Sun Yat-sen University | |
| Comparison Between Two Different High Power Ablative Lasers in the Treatment of Oral Leukoplakia | NCT03233165 | Leukoplakic Les... | Er:YAG laser Er,Cr:YSGG lase... | - | University of Zagreb | |
| Endoscopic Submucosal Dissection vs Local Laparoscopic Surgical Resection (TAMIS/TEO) in Early Rectal Neoplasias | NCT03959839 | Rectal Neoplasm... | ESD TAMIS TEO | 18 Years - | Puerta de Hierro University Hospital | |
| Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma | NCT06087068 | Thyroid Cancer Surgery Recurrence | Thyroxine | 18 Months - 70 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer | NCT04826029 | Advanced Stage ... Advanced Stage ... Advanced Stage ... | Standard strate... Follow-up strat... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III | NCT02761070 | Glioblastoma Recurrence Progression | Temozolomide Bevacizumab | 20 Years - 75 Years | Kyorin University | |
| Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP | NCT02983097 | Diffuse Large B... Follicular Lymp... Mantle Cell Lym... Burkitt Lymphom... Aggressive Marg... | Rituximab Cisplatin Carboplatin Dexamethasone Cytarabine Lenalidomide PegFilgrastim peripheral stem... | 18 Years - 70 Years | Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | |
| Robotic Radical Cystectomy Outcomes | NCT04900558 | Bladder Cancer Muscle-Invasive... Oncology Recurrence Surgery | Radical Cystect... | 18 Years - | University of Florence | |
| Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) | NCT01447667 | Hepatic Fibrosi... Hepatocellular ... | Magnetic resona... | 18 Years - 80 Years | Seoul National University Hospital | |
| Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer | NCT04439812 | Stomach Neoplas... | Observation | - | Hospital Universitario Ramon y Cajal | |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer | NCT05704829 | HER2-positive E... | Trastuzumab der... Standard-of-Car... | 18 Years - | West German Study Group | |
| A Multicenter RCT Study of 3DV Technology in the Diagnosis and Treatment of PLC | NCT05118451 | Primary Liver C... | 3 d visualizati... | 18 Years - 66 Years | Zhujiang Hospital | |
| Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients | NCT06389201 | Nasopharyngeal ... | HCQ Placebo | 20 Years - 70 Years | Affiliated Hospital of Nantong University | |
| Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC | NCT00234182 | Hepatocellular ... | Interferon alph... | 18 Years - 75 Years | The University of Hong Kong | |
| The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma | NCT02525965 | Hepatocellular ... | Wide resection ... Narrow resectio... | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection | NCT03183115 | Esophageal Squa... | Radiofrequency ... Endoscopy Lugol's Solutio... | 20 Years - 90 Years | E-DA Hospital | |
| Survival Rates and Quality of Life According to Follow-up Period After Gastrectomy for Gastric Cancer (STOFOLUP) | NCT04740346 | Gastric Cancer Recurrence Quality of Life | Computed tomogr... | 19 Years - | National Cancer Center, Korea | |
| Intravesically Heated Thermo-chemotherapy With Mitomycin-C Prior to TURBT | NCT02471547 | Transitional Ce... | BWT with Mitomy... | 18 Years - | Sheba Medical Center | |
| Mesalazine Effects in Sporadic Colorectal Adenoma Patients | NCT01894685 | Sporadic Colore... | Mesalazine Placebo | 50 Years - 75 Years | UMC Utrecht | |
| RFA to Prevent Metachronous Squamous Neoplasia Recurrence After Complete Endoscopic Submucosal Dissection | NCT03183115 | Esophageal Squa... | Radiofrequency ... Endoscopy Lugol's Solutio... | 20 Years - 90 Years | E-DA Hospital | |
| Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer | NCT06235853 | Non-muscle Inva... Cystoscopy Recurrence Progression Bladder Cancer Biomarkers | Blood serum: sU... Urine: IL-8, AP... | 18 Years - | Wroclaw Medical University | |
| Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma | NCT03457389 | Pituitary Adeno... Prolactinoma Pituitary Tumor Recurrence Tumo... | Cabergoline | 19 Years - | Seoul National University Hospital | |
| Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III | NCT02761070 | Glioblastoma Recurrence Progression | Temozolomide Bevacizumab | 20 Years - 75 Years | Kyorin University | |
| Endoscopic Treatment of Bronchial Carcinoid Tumors | NCT03723499 | Carcinoid Tumor | Medical data co... | 18 Years - | Centre Hospitalier Universitaire de Saint Etienne | |
| Bevacizumab for Recurrent Malignant Glioma | NCT00271609 | Recurrent High-... Malignant Gliom... | Bevacizumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Long-term Outcome After Pit-pick for Simple Pilonidal Sinus Disease | NCT05027607 | Pilonidal Sinus... | Bascom's pit-pi... | 14 Years - 99 Years | Nordsjaellands Hospital | |
| Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma | NCT05483257 | Pancreatic Canc... | Multigene panel... | 34 Years - 84 Years | Ruijin Hospital | |
| Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma | NCT00460681 | Hepatocellular ... | Thymopentin | 18 Years - 75 Years | Fudan University | |
| A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer | NCT06082180 | Thyroid Cancer Recurrence | prophylactic ce... | 18 Years - 70 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation | NCT02046356 | Hepatocellular ... | MESS-RFA | 18 Years - 70 Years | Southwest Hospital, China | |
| Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation | NCT06041490 | Liver Transplan... Hepatocarcinoma Recurrent Osteo... High-Risk Cance... | multi-kinase in... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
| Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission | NCT02324439 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Omega Nutrition... | 21 Years - | Southern Illinois University | |
| Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma | NCT03457389 | Pituitary Adeno... Prolactinoma Pituitary Tumor Recurrence Tumo... | Cabergoline | 19 Years - | Seoul National University Hospital | |
| Salvage Chemoradiation Therapy for Recurrence After Radical Surgery or Palliative Surgery in Esophageal Cancer Patients | NCT03731442 | Esophageal Canc... | Involved field ... Elective field ... Paclitaxel Platinum PEG-rhG-CSF | 16 Years - 70 Years | ChineseAMS | |
| Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation | NCT05910970 | Hepatocellular ... Recurrence Immune Checkpoi... | Adjuvant tislel... Adjuvant tislel... | 18 Years - 70 Years | Guangxi Medical University | |
| Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma | NCT01972750 | First or Second... | Dovitinib | 18 Years - 100 Years | University Hospital, Bonn | |
| Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study | NCT05229471 | Cancer Venous Thromboe... Recurrence | 18 Years - 120 Years | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | ||
| Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT | NCT03114670 | Adult Acute Mye... | CD123CAR-41BB-C... | 18 Years - | Affiliated Hospital to Academy of Military Medical Sciences | |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer | NCT05704829 | HER2-positive E... | Trastuzumab der... Standard-of-Car... | 18 Years - | West German Study Group | |
| Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy | NCT02399033 | Hepatocellular ... | Xihuang Capsule... | 20 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection | NCT02867280 | Hepatocellular ... Recurrence | Sorafenib | 18 Years - 75 Years | Sun Yat-sen University | |
| Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | NCT02341989 | Testicular Neop... Seminoma | Bleomycin Etopo... Carboplatin | 18 Years - 60 Years | St. Olavs Hospital | |
| The HELPP Score: A Pretreatment Score to Predict Survival in Pancreatic Cancer | NCT05752812 | Pancreatic Aden... | 18 Years - 99 Years | Medical University of Vienna | ||
| Lung Cancer Patients' Attitudes to a Second Course of Radiotherapy | NCT04813068 | Lung Cancer Recurrence | Semi-structured... | 18 Years - | NHS Greater Glasgow and Clyde | |
| The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) | NCT00397540 | Carcinoma, Hepa... Chronic Hepatit... | PEIT RFTA | 19 Years - 80 Years | Seoul National University Hospital | |
| A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) | NCT03121768 | Oncology Bladder Cancer Superficial Bla... Recurrence Progression BCG | 18 Years - | Mansoura University | ||
| Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence | NCT01539785 | First Recurrenc... | Secondary citor... Hyperthermic in... | 18 Years - 70 Years | Catholic University of the Sacred Heart | |
| Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH | NCT02587884 | Hepatocellular ... | TACE | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Percutaneous Nephroscopic Treatment of Parapelvic Cysts | NCT05504512 | Kidney Stone Parapelvic Cyst Kidney Diseases Recurrence | No intervention | 18 Years - 70 Years | Xiangya Hospital of Central South University | |
| Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission | NCT02324439 | Epithelial Ovar... Fallopian Tube ... Primary Periton... | Omega Nutrition... | 21 Years - | Southern Illinois University | |
| Prognostic Value of CTC in HNSCC Patients | NCT01884129 | Recurrence Metastasis Death | 20 Years - | Chang Gung Memorial Hospital | ||
| Validation of DNA Methylation Biomarkers for Oral Cancer Detection | NCT02648789 | Oral Cancer Recurrence | 20 Years - 75 Years | Taipei Veterans General Hospital, Taiwan | ||
| Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma | NCT02586285 | Hepatocellular ... | S-Adenosyl Meth... | 18 Years - 70 Years | Eastern Hepatobiliary Surgery Hospital | |
| Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL) | NCT00440726 | Acute Lymphobla... | Bortezomib Dexamethasone PEG-asparaginas... Doxorubicin Cytarabine Methotrexate Vincristine Triple IT Thera... | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Efficacy of Optically-guided Surgery in the Management of Early-staged Oral Cancer - COOLS TRIAL | NCT01039298 | Oral Cancer High-grade Prec... | Fluorescence vi... Fluorescence vi... | 19 Years - | University of British Columbia | |
| A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent Glioblastoma Multiforme (GBM) | NCT02766699 | Glioblastoma Astrocytoma, Gr... | EGFR(V)-EDV-Dox | 18 Years - | Engeneic Pty Limited | |
| A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection | NCT03914352 | Hepatocellular ... | PD-1 antibody TACE | 18 Years - 75 Years | Cancer Hospital of Guangxi Medical University | |
| Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors | NCT04400357 | Pancreatic Aden... Pancreatic Cyst... Pancreatic Endo... Chronic Pancrea... Cholangiocarcin... Ampullary Adeno... Duodenal Adenoc... | Robotic pancrea... Open pancreatic... | 18 Years - | Ruijin Hospital | |
| Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention | NCT02035631 | Breast Neoplasm... Recurrence | Diet Physical activi... Minimal diet in... Minimal physica... | 18 Years - 75 Years | Institut Català d'Oncologia | |
| Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours | NCT02804815 | Cancer Breast Cancer Prostate Cancer Colorectal Canc... Gastro-oesophag... | Aspirin 100mg Aspirin 300mg Placebo 100mg Placebo 300mg | 16 Years - | University College, London | |
| Long-term Anastrozole Versus Tamoxifen Treatment Effects | NCT01745289 | Breast Cancer | 18 Years - | Queen Mary University of London | ||
| Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection | NCT00561522 | Hepatocellular ... Neoplasm Metast... | Capecitabine No other preven... | 18 Years - 79 Years | Fudan University | |
| Validation of DNA Methylation Biomarkers for Oral Cancer Detection | NCT02648789 | Oral Cancer Recurrence | 20 Years - 75 Years | Taipei Veterans General Hospital, Taiwan |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
